Cargando…
Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome
Background: BMS is a chronic pain syndrome affecting the oral mucosa. It consists of experiencing a burning or dysesthetic sensation. BMS prevalence varies, with up to 15% among women. An effective treatment is still unattainable. Material and Methods: A total of 60 patients with BMS qualified for a...
Autores principales: | Zborowski, Jacek, Konopka, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330819/ https://www.ncbi.nlm.nih.gov/pubmed/35897370 http://dx.doi.org/10.3390/ijerph19158999 |
Ejemplares similares
-
Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome
por: Castillo-Felipe, Candela, et al.
Publicado: (2022) -
Careful use of clonazepam and alpha lipoid acid in burning mouth syndrome treatment
por: Suga, Takayuki, et al.
Publicado: (2021) -
Therapeutic effects of clonazepam in patients with burning mouth syndrome and various symptoms or psychological conditions
por: Shin, Hyun-Il, et al.
Publicado: (2023) -
A Comparison of Clinical Efficiency of Photodynamic Therapy and Topical Corticosteroid in Treatment of Oral Lichen Planus: A Split-Mouth Randomised Controlled Study
por: Zborowski, Jacek, et al.
Publicado: (2021) -
GERD—A Burning Problem after Sleeve Gastrectomy?
por: Znamirowski, Przemysław, et al.
Publicado: (2021)